World Class Speakers
The World Biosimilar Congress agenda will feature 300+ speakers across multiple streams.
Speakers will come from the most successful, innovative and thought-provoking companies from around the world. They will be supported by leading suppliers from the mega tech companies to the latest start-ups who are shaking up the industry.
APPLY TO SPEAK
Meet our 2017 speakers
Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc
Philip Ball, Market Access Manager, Napp Pharmaceuticals
Fereshteh Barei, Health Economist, LEGOS Paris Dauphine University
Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre
Caroline Boulliat, Immunology, Oncology. Biosimilar Business Unit Head, Amgen Europe Gmbh
Joanna Brougher, Owner & Principal, BioPharma Law Group, PLLC, Biotech, Pharma and Medical Device IP and Corporate Co, BioPharma Law Group PLLC
Divya Chadha Manek, Head of Business Development (Commercial), National Institute for Health Research (NIHR)
Dan Cimpoeru, Board Member, European Cancer Patient Coalition
Anne Cook, Biologicals Quality Assessor, M.H.R.A.
Margaret Dolan, Regional Pharmacy Procurement Specialist, N.H.S.
Pieter Dylst, Senior Manager Market Access, Medicines for Europe
Catherine Evans, Business Development Manager for Biopharma, Bruker U.K. Ltd
Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe
Francois Xavier Frapaise MD, CMO, Merck Biosimilars
Uwe Gudat, Head of Safety, Biosimilars, Merck & Cie
Jatinder Harchowal, Jatinder Harchowal Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Royal Marsden NHS Foundation Trust
Ian Henshaw, Head of Business Operations, Biogen
Forrest Hu, General Manager of International Business, 3SBio Inc
Ruediger Jankowsky, Managing Director, Cinfa Biotech
Peter Jorgensen, Chief Executive Officer, I.G.L.
Parminder Kaur, CEO, RegPak BioPharma Consulting
Tarek Kilani, Former Head of Pharmacy & Continuing Medical Education Coordinator, Emirates French Hospital Llc
Martin Knight, Sr. Director, Strategy & Planning, Inflammation, Infectious Disease and General Medicine, Covance
Jenny Koppelkamm, Market Access Director, Takeda
William Christopher Lamanna, Laboratory Head of Protein Characterization, Sandoz Inc
Adam Levysohn, Head of Global Market Access Biogen Biosimilars Business Unit, Biogen
Patrick Liu, Vice President of Global Biologics R&D and Head of Biologics, Assays and Technology, Teva Pharmaceuticals U.S.A.
Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway
Márcia Martini Bueno, Institucional Affairs Director, Libbs Pharmaceutica Ltda
Victor Lino Mendonça, VP Global Policy & Market Access Europe, Mylan
Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)
Cecil Nick, Vice President, PAREXEL
Ber Oomen, Executive Secretary and Treasurer, European Specialist Nurses Organisations
Mareike Ostertag, Director Regulatory and Science Policy, Novartis Pharma AG
Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines
Joaquin Rodrigo, Founder President, BIOSIM Spanish Association of Biosimilars
Dr Stacie Ropka, Partner, Axinn
Karsten Roth, Director Clinical Operations, Cinfa Biotech
Ingrid Schwarzenberger, Head of Global Regulatory Affairs Biopharmaceuticals, Sandoz Biopharmaceuticals Gmbh
Anjan Selz, Vice President – Head of Biosimilars EMEA, Lupin Europe Ltd
Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc
Shantreddy Soogareddy, Associate Director - External Development R&D (Alliance and Project management), Dr. Reddy's Laboratories Limited
George Stefanov, Marketing Operations Director Biologics, Europe, Mylan
Don Stewart, President and Chief Executive Officer, PlantForm Corporation
Gianluca Trifirò, Assistant Professor of Pharmacology, University of Messina
Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz
Jonathan Underhill, Associate Director for Medicines Evidence, NICE
Manfred Weiler, Senior Vice President, Medical & Scientific Strategy, INC Research
Robert Wojciechowski, Vice President, Global Regulatory Consulting, INC Research/inVentiv Health
Elena Wolff-Holz, Elena Wolff-Holz, Chair, Biosimilar Medicinal Products Working Party (BMWP), Paul Ehrlich Institut
René Wuttke, Bioanalytical Principal Investigator, Global Bioanalytical Services, Celerion Inc.